  In today's environment there is more and more pressure from your payers and patients. There's a need to get outcomes more quickly and to save costs to the payer. The prescription drug market is also under heavy scrutiny. There are now thousands of pending suits against anti-inflammatory and pain drugs, with many more to come. In addition, national treatment guidelines (ACOEM in particular) have published statements indicating that pain medications are typically not useful in the subacute and chronic phases and have been shown to be the most important factor impeding recovery of function. This is what H-Wave can help you with. We want to show you, and the payers, that H-Wave is a treatment option with less health risks, great results, and cost savings. Over 76% of patients that take an H-Wave home increase their function levels in the first 30 days and over 63% of patients decrease their medication usage in the first 30 days. These are the keys to recovery and return to work and other daily activities. Home H-Wave provides a real therapy option, which can reduce the need for other more expensive and less convenient treatments. In addition, if H-Wave isn't showing these objective findings after the first 30-days you simply refrain from signing a continued Rx and we refund the entire charge as part of our money-back guarantee program. The home H-Wave program offers many positives for the patient, doctor, employer and insurance company with no health or financial risk! Not only is H-Wave convenient for the patient, it is very easy on you and your office staff. H-Wave will work with insurance companies to obtain all necessary authorizations and perform all billing. Trained H-Wave representatives will deliver each piece of equipment to the patient, and provide a complete treatment and personalized instructional session. Outcomes derived from home H-Wave use are documented and sent to you (the prescribing physician) in a comprehensive report. This allows you to monitor patient progress more effectively and document outcomes. |
